What's new

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 18, Status: Authorised

Feb 25, 2025 - 14:27
 0
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Trumenba, meningococcal group b vaccine (recombinant, adsorbed), Date of authorisation: 24/05/2017, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

GM orders periodic halts at its Corvette assembly plant

Next Article

GLP-1s – The perspectives of two CEOs

Related Posts

Implementation strategy of ICH Guideline M12 on drug in...

Feb 13, 2025  0

Herbal medicinal product: Betulae folium, Betula pendula Roth,Betula pubescens Ehrh., F: Assessment finalised

Herbal medicinal product: Betulae folium, Betula pendul...

Feb 28, 2025  0

EMEA-000786-PIP01-09-M02

EMEA-000786-PIP01-09-M02

Feb 26, 2025  0